Clinical Trial Update: UNFOLD Study Egypt

View source ↗

Summary

The UNFOLD study conducted in Egypt sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED